Wednesday, 28 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14759
Articles
Company
Drug
Fosun Pharmaceutical’s HanDaYuan Seeks NMPA Approval for Expanded Indications in Autoimmune Treatments
March 7, 2025
Policy / Regulatory
CDE Streamlines Patent Dispute Resolution for Generic Drug Filings with New Online Submission Process
October 20, 2024
Company
Drug
Jiangsu Hengrui Receives NMPA Approval for HRS-1167 Clinical Trials in Advanced Solid Tumors
December 3, 2024
Company
Drug
Innovent Biologics Launches Phase I Study for IBI3002, a Bispecific Antibody Targeting Asthma
October 20, 2024
Company
Drug
CDE Grants Priority Review to Jiu An’s Adrenaline and AnHeart’s Taletrectinib; Two Others Earn Breakthrough Therapy Designation
October 20, 2024
Company
Legal / IP
Sandoz Agrees to $265 Million Settlement in U.S. Generic Drug Antitrust Case
October 20, 2024
Company
Drug
Huadong Medicine’s MaiLi Extreme Achieves Clinical Study Milestone for Chin Retraction Treatment
October 20, 2024
Company
Medical Device
ARSMO Plastic Aesthetic Hospital Introduces Liquid PCL Implant GOURI in Hainan
October 20, 2024
Company
Drug
CARsgen Therapeutics’ BCMA-targeted CAR-T Cell Therapy Approved by China’s NMPA
October 20, 2024
Company
Deals
Takeda Partners with Biological E to Boost Production of Dengue Vaccine QDenga
October 21, 2024
Company
Drug
FDA Withdraws Approval for Multiple Myeloma Drug Pepaxto Over Safety and Efficacy Concerns
October 21, 2024
Company
Drug
Chia Tai Tianqing’s Anlotinib-Benmelstobart Combo Therapy Receives CDE Review for Endometrial Cancer
December 9, 2024
1
2
…
780
781
782
783
784
…
1,229
1,230
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?